Silk Road Medical Inc. (SILK), a medical device company, expects to turn in double-digit revenue growth this year too, thanks to growing adoption of TCAR.
Transcarotid Artery Revascularization, or TCAR in short, is a minimally invasive procedure that can clear blockages and open a narrowed carotid artery. It is estimated that 4.3 million people in the U.S. suffer from carotid artery disease. Nearly 34% of ischemic strokes are caused by carotid artery disease.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com